tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market
AKTX
Akari Therapeutics
RESEARCH TOOLSreports
Want to see AKTX full AI Analyst Report?

Akari Therapeutics (AKTX) Financial Statements

376 Followers

Akari Therapeutics Financial Overview

Akari Therapeutics's market cap is currently $18.81M. The company's EPS TTM is $-1448; its P/E ratio is -0.01; Akari Therapeutics is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -17.27M$ -21.64M$ -16.81M$ -23.09M$ -17.21M
EBITDA$ -17.35M$ -19.53M$ -16.80M$ -23.08M$ -17.21M
Net Income$ -17.30M$ -19.79M$ -10.01M$ -17.75M$ -17.42M
Balance Sheet
Cash & Short-Term Investments$ 5.20M$ 2.60M$ 3.85M$ 13.25M$ 9.36M
Total Assets$ 47.89M$ 50.56M$ 4.36M$ 13.83M$ 11.65M
Total Debt$ 754.00K$ 3.26M$ 0.00$ 0.00$ 0.00
Net Debt$ -4.45M$ 661.00K$ -3.85M$ -13.25M$ -9.36M
Total Liabilities$ 19.56M$ 28.33M$ 4.58M$ 12.04M$ 6.09M
Stockholders' Equity$ 28.33M$ 22.23M$ -229.00K$ 1.79M$ 5.55M
Cash Flow
Free Cash Flow$ -10.57M$ -12.55M$ -16.43M$ -21.50M$ -18.85M
Operating Cash Flow$ -10.57M$ -12.55M$ -16.43M$ -21.50M$ -18.85M
Investing Cash Flow$ 0.00$ 382.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 13.17M$ 10.99M$ 7.02M$ 25.29M$ 14.29M
Currency in USD

Akari Therapeutics Earnings and Revenue History

Income Statement >

Akari Therapeutics Debt to Assets

Balance Sheet >

Akari Therapeutics Cash Flow

Cash Flow >

Akari Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >